CN Patent

CN102802604B — 含有硼酸盐-多元醇复合物的水性药物组合物

Assigned to Alcon Research Co ltd · Expires 2016-02-10 · 10y expired

What this patent protects

本发明涉及提供多剂量的眼用组合物。所述组合物具有足够的抗微生物活性，从而满足USP的防腐效力要求以及类似的防腐标准(例如，EP和JP)的。所述组合物包含至少两种不同的多元醇、硼酸盐和低浓度的苯扎氯铵。

USPTO Abstract

本发明涉及提供多剂量的眼用组合物。所述组合物具有足够的抗微生物活性，从而满足USP的防腐效力要求以及类似的防腐标准(例如，EP和JP)的。所述组合物包含至少两种不同的多元醇、硼酸盐和低浓度的苯扎氯铵。

Drugs covered by this patent

levocetirizine-dihydrochloride (LEVOCETIRIZINE DIHYDROCHLORIDE)

Patent Metadata

Patent number: CN102802604B
Jurisdiction: CN
Classification: —
Expires: 2016-02-10
Drug substance claim: No
Drug product claim: No
Assignee: Alcon Research Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.